References
- 1. CICHOŻ-LACH H., MICHALAK A. Liver injury in the era of COVID-19. World journal of gastroenterology 2021;27(5): 377.
- 2. DONG ZY, et al. The prevalence of gastrointestinal symptoms, abnormal liver function, digestive system disease and liver disease in COVID-19 infection: a systematic review and meta-analysis. Journal of Clinical Gastroenterology 2021; 55(1): 67.
- 3. KUNUTSOR SK., LAUKKANEN JA. Markers of liver injury and clinical outcomes in COVID-19 patients: a systematic review and meta-analysis. Journal of Infection 2021; 82(1): 159–198.
- 4. NARDO AD, et al. Pathophysiological mechanisms of liver injury in COVID-19. Liver International 2021; 41(1): 20–32.
- 5. JOTHIMANI D, VENUGOPAL R, ABEDIN MF, KALIAMOORTHY I, RELA M. COVID-19 and Liver [published online ahead of print, 2020 Jun 15]. J Hepatol. 2020; S0168-8278(20)30377–9.
- 6. https://www.covid-hep.net/
- 7. ALQAHTANI SA, SCHATTENBERG JM. Liver injury in COVID-19: The current evidence. United European Gastroenterol J. 2020;8(5):509–519.
- 8. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel: Chair; Panel members; EASL Governing Board representative: EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019 Jun;70(6):1222–1261
- 9. GARRIDO I, LIBERAL R, MACEDO G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52(2):267–275. doi:10.1111/apt.15813
- 10. https://www.ncbi.nlm.nih.gov/books/NBK547961/ [accessed 25 July 2020]
- 11. https://www.who.int/news-room/detail/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19 [accessed 25 July 2020]
- 12. MARJOT, T, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hep 2021; 74(3): 567–577
- 13. SHAO, J., et al. Implications of liver injury in risk-stratification and management of patients with COVID-19. Hepatology international (2021): 1–11.
- 14. SIKKEMA, B. J., NICOLAAS, JS., VAN WIJNGAARDEN P. No association between COVID-19 related liver injury and the course of disease: a retrospective study. Scandinavian Journal of Gastroenterology 2021; 56(1): 68–71.
- 15. YA-WEN A., et al. Liver function recovery of COVID-19 patients after discharge, a follow-up study. International journal of medical sciences 2021; 18 (1): 176.
- 16. HAMID S., et al. WGO Guidance for the Care of Patients with COVID-19 and Liver Disease. Journal of Clinical Gastroenterology 2021; 55 (1): 1.
- 17. ZHANG C, SHI L, WANG FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428-430.
- 18. https://www.who.int/publications/i/item/clinical-management-of-covid-19